SE9601556D0 - New pharmaceutical formulation of a thrombin inhibitor for parenteral use - Google Patents

New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Info

Publication number
SE9601556D0
SE9601556D0 SE9601556A SE9601556A SE9601556D0 SE 9601556 D0 SE9601556 D0 SE 9601556D0 SE 9601556 A SE9601556 A SE 9601556A SE 9601556 A SE9601556 A SE 9601556A SE 9601556 D0 SE9601556 D0 SE 9601556D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulation
parenteral use
thrombin inhibitor
new pharmaceutical
inhibitor
Prior art date
Application number
SE9601556A
Other languages
English (en)
Swedish (sv)
Inventor
Anna Lundgren
Ulla Stjernfelt
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9601556A priority Critical patent/SE9601556D0/xx
Publication of SE9601556D0 publication Critical patent/SE9601556D0/xx
Priority to ZA9703062A priority patent/ZA973062B/xx
Priority to ARP970101517A priority patent/AR006664A1/es
Priority to IDP971318A priority patent/ID17334A/id
Priority to AU27195/97A priority patent/AU2719597A/en
Priority to PCT/SE1997/000676 priority patent/WO1997039770A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9601556A 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use SE9601556D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9601556A SE9601556D0 (sv) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use
ZA9703062A ZA973062B (en) 1996-04-24 1997-04-10 New pharmaceutical formulation of a thrombin inhibitor for parenteral use.
ARP970101517A AR006664A1 (es) 1996-04-24 1997-04-15 Formulacion de liberacion extendida de un inhibidor de trombina soluble en agua para administracion parenteral, proceso para su preparacion, metodo paraprofilaxis y/o tratamiento del tromboembolismo arterial y/o venoso y uso de un inhibidor de trombina
IDP971318A ID17334A (id) 1996-04-24 1997-04-21 Formulasi farmasi suatu inhibitor trombin terbaru yang digunakan secara parenteral
AU27195/97A AU2719597A (en) 1996-04-24 1997-04-22 New pharmaceutical formulation of a thrombin inhibitor for parenteral use
PCT/SE1997/000676 WO1997039770A1 (en) 1996-04-24 1997-04-22 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601556A SE9601556D0 (sv) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Publications (1)

Publication Number Publication Date
SE9601556D0 true SE9601556D0 (sv) 1996-04-24

Family

ID=20402321

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601556A SE9601556D0 (sv) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Country Status (6)

Country Link
AR (1) AR006664A1 (xx)
AU (1) AU2719597A (xx)
ID (1) ID17334A (xx)
SE (1) SE9601556D0 (xx)
WO (1) WO1997039770A1 (xx)
ZA (1) ZA973062B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
FR2793418B1 (fr) * 1999-05-11 2001-07-27 Synthelabo Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee
SE9902202D0 (sv) 1999-06-10 1999-06-10 Astra Ab Production of aggregates
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
GB0014136D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
PE20020300A1 (es) 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
IN2014MN02245A (xx) * 2012-04-10 2015-10-09 Rubicon Res Private Ltd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
DK93993D0 (da) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg Anvendelse af 2-hydroxypropyl-beta-cyclodextrin til fremstilling af et systemisk analgetisk opioidpraeparat

Also Published As

Publication number Publication date
ZA973062B (en) 1997-10-24
AR006664A1 (es) 1999-09-08
AU2719597A (en) 1997-11-12
ID17334A (id) 1997-12-18
WO1997039770A1 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
ID19198A (id) Inhibitor metaloprotease heterosiklik
DK0869966T3 (da) Prodrugs for thrombin-inhibitorer
ID18416A (id) Inhibitor metaloprotease diheterosiklik
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
NO985874D0 (no) Bestemte fosfinylderivater nyttige som naaladase inhibitorer
NO973657D0 (no) Trombin-inhibitorer
NO981938D0 (no) Proteaseinhibitorer
NO973764D0 (no) Nye dipeptidamidiner som trombin-inhibitorer
NO990548L (no) Inhibitorer for cystein-protease
DK0858464T3 (da) Thrombin-inhibitorer
ATE234091T1 (de) Thrombin inhibitoren
ATE268781T1 (de) Thrombininhibitoren
EE9800044A (et) Prolüülendopeptidaasi inhibiitorid
ATE228760T1 (de) Thrombininhibitoren
NO983283D0 (no) Hydrokamsyre-baserte Kollagenase-inhibitorer
DE69731664D1 (de) Thrombininhibitoren
NO20000094D0 (no) 6-Azaurcilderivater som IL-5 inhibitorer
DE69717147T2 (de) Thrombin inhibitoren
ID19929A (id) Inhibitor naaladase
ID17400A (id) Inhibitor naaladase
LV5826A4 (lv) Tienamicina inaktivejosas nieru peptidazes inhibitors